These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 372589)

  • 21. Renal transplantation in a Community Hospital.
    Sellers AL; Llach F; Franklin S; Gordon A; Fichman M
    JAMA; 1976 Dec; 236(25):2866-9. PubMed ID: 792489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The association of cyclosporine with the 1-year costs of cadaver-donor kidney transplants.
    Showstack J; Katz P; Amend W; Salvatierra O
    JAMA; 1990 Oct; 264(14):1818-23. PubMed ID: 2402040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preemptive living donor renal transplantation: a single-center experience.
    Haberal M; Karakayali H; Sevmis S; Akbulut S; Colak T; Baskin E; Moray G; Torgay A; Arslan G
    Transplant Proc; 2009 Sep; 41(7):2764-7. PubMed ID: 19765429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of hemodialysis versus cadaveric transplantation.
    Kreis H
    Kidney Int Suppl; 1978 Jun; (8):S91-4. PubMed ID: 357819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The UNOS Scientific Renal Transplant Registry--1991.
    Cecka JM; Terasaki PI
    Clin Transpl; 1991; ():1-11. PubMed ID: 1820108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic analysis of the treatment of end-stage renal disease treatment: living-donor kidney transplantation versus hemodialysis.
    Sánchez-Escuredo A; Alsina A; Diekmann F; Revuelta I; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Campistol JM; Oppenheimer F; Fernandez E
    Transplant Proc; 2015; 47(1):30-3. PubMed ID: 25645763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of alternative technologies for the treatment of end-stage renal disease.
    Krakauer H
    Isr J Med Sci; 1986; 22(3-4):245-59. PubMed ID: 3091531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
    Reddy KS; Stablein D; Taranto S; Stratta RJ; Johnston TD; Waid TH; McKeown JW; Lucas BA; Ranjan D
    Am J Kidney Dis; 2003 Feb; 41(2):464-70. PubMed ID: 12552511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Costs of hemodialysis and kidney transplantation in Sudan: a single center experience.
    Elsharif ME; Elsharif EG; Gadour WH
    Iran J Kidney Dis; 2010 Oct; 4(4):282-4. PubMed ID: 20852367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of renal transplantation of the Hashemi Nejad Kidney Hospital--Tehran.
    Ghods AJ; Ossareh S; Savaj S
    Clin Transpl; 2000; ():203-10. PubMed ID: 11512314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts is cost-effective.
    McLaughlin K; Manns B; Nickerson P
    Transplantation; 2006 May; 81(9):1278-84. PubMed ID: 16699455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preemptive living-donor renal transplantation: outcome and clinical advantages.
    Yoo SW; Kwon OJ; Kang CM
    Transplant Proc; 2009; 41(1):117-20. PubMed ID: 19249492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cadaver kidney allocation in the north Italy transplant program on the eve of the new millennium.
    Sirchia G; Poli F; Cardillo M; Scalamogna M; Rebulla P; Taioli E; Remuzzi G; Nocera A
    Clin Transpl; 1998; ():133-45. PubMed ID: 10503092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of preemptive renal transplantation versus waiting time on dialysis.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2002; ():367-77. PubMed ID: 12971463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cost-effectiveness analysis of treatment for end-stage renal disease].
    Asgeirsdóttir TL; Asmundsdóttir G; Heimisdóttir M; Jónsson E; Pálsson R
    Laeknabladid; 2009 Nov; 95(11):747-53. PubMed ID: 19996463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of end-stage renal disease in children: a 15-year experience.
    Potter DE; Holliday MA; Piel CF; Feduska NJ; Belzer FO; Salvatierra O
    Kidney Int; 1980 Jul; 18(1):103-9. PubMed ID: 7012418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients.
    Ojo AO; Hanson JA; Wolfe RA; Agodoa LY; Leavey SF; Leichtman A; Young EW; Port FK
    Kidney Int; 1999 May; 55(5):1952-60. PubMed ID: 10231459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.
    Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW
    N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.